Total synthesis of rhizoxin D

Tetrahedron Letters

Volumn 38, Issue 39, 1997, Pages 6825-6828

  Williams, David R ^a   Werner, Kim M ^a   Feng, Bainian ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RHIZOXIN; RHIZOXIN D; UNCLASSIFIED DRUG;

ARTICLE; DIASTEREOISOMER; DRUG SYNTHESIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION; REACTION ANALYSIS;

EID: 0030839481     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(97)01605-5     Document Type: Article

References (36)

1. Tsuruo, T.; Oh-hara, T.; Iida, H.; Tsukagoshi, S.; Sato, Z.; Matsuda, I.; Iwasaki, S.; Okuda, S.; Shimizu, F.; Sasagawa, K.; Fukami, M.; Fukuda, K.; Arakawa, M. Cancer Res. 1986, 46, 381. Iwasaki, S.; Kobayashi, H.; Furukawa, J.; Namikoshi, M.; Okuda, S.; Sato, Z.; Matsuda, I.; Noda. T. J. Antibiot. 1984, 37, 354.
2. Tsuruo, T.; Oh-hara, T.; Iida, H.; Tsukagoshi, S.; Sato, Z.; Matsuda, I.; Iwasaki, S.; Okuda, S.; Shimizu, F.; Sasagawa, K.; Fukami, M.; Fukuda, K.; Arakawa, M. Cancer Res. 1986, 46, 381. Iwasaki, S.; Kobayashi, H.; Furukawa, J.; Namikoshi, M.; Okuda, S.; Sato, Z.; Matsuda, I.; Noda. T. J. Antibiot. 1984, 37, 354.
3. a) Iwasaki, S.; Namikoshi, M.; Kobayashi, H.; Furukawa, J.; Okuda, S. Chem. Pharm. Bull. 1986, 34, 1387.
4. b) Kiyoto, S.; Kawai, Y.; Kawakita, T.; Kino, E.; Okuhara, M.; Uchida, I.; Tanaka, H.; Hashimoto, M.; Terano, H.; Kohsaka, M.; Aoki, H.; Imanaka, H. J. Antibiot. 1986, 39, 762.
5. Although the rhizoxin diene 2 was not named by investigators responsible for its discovery (ref. 2a), we have referred to this natural product as rhizoxin D. An account of our total synthesis was previously presented: Williams, D.R.; Werner, K.M.; Feng, B. National Meeting; American Chemical Society, 1996, 211th, ORGN 442 (New Orleans).
6. a) Iwasaki, S.; Namikoshi, M.; Kobayashi, H.; Furukawa, J.; Okuda, S.; Itai, A.; Kasuya, A.; Iitaka, Y.; Sato, Z. J. Antibiot. 1986, 39, 424.
7. b) Kobayashi, H.; Iwasaki, S.; Yamada, E.; Okuda, S. Chem. Commun. 1986, 1702.
8. Takashi, M.; Iwasaki, S.; Kobayashi, H.; Okuda, S.; Murai, T.; Sato, Y.; Haraguchi-Hiraoka, T.; Nagano, H. J. Antibiot. 1987, 40, 66.
9. a) Kato, Y.; Ogawa, Y.; Imada, T.; Iwasaki, S.; Shimazaki, N.; Kobayashi, T.; Komai, T. J. Antibiot. 1991, 44, 66.
10. b) Takigawa, N.; Ohnoshi, T.; Ueoka, H.; Horiguchi, T. Gan. To. Kagaku Ryoho, 1993, 20, 1221.
11. a) Takahashi, M.; Iwasaki, S.; Kobayashi, H.; Okuda, S.; Murai, T.; Sato, Y. Biochim. Biophys. Acta, 1987, 926, 215.
12. b) Hamel, E. Pharmac. Ther. 1992, 55, 31.
13. Recent investigations have demonstrated that the 100th amino acid (Asn-100) of β-tubulin is essential for rhizoxin-binding: Li, Y.; Kobayashi, H.; Hashimoto, Y.; Iwasaki, S. Biochem. Biophys. Res. Commun. 1992, 187, 722.
14. Hendriks, H.R.; Plowman, J.; Berger, D.P.; Paull, K.D. Ann. Oncol. 1992, 3, 755.
15. a) Nakada, M.; Kobayashi, S.; Iwasaki, S.; Ohno, M. Tetrahedron Lett. 1993, 34, 1035.
16. b) Nakada, M.; Kobayashi, S.; Shibasaki, M.; Iwasaki, S.; Ohno, M. Tetrahedron Lett. 1993, 34, 1039.
17. Kende, A.S.; Blass, B.E.; Henry, J.R. Tetrahedron Lett. 1995, 36, 4741.
18. For recent efforts: a) Kobayashi, S.; Nakada, M.; Ohno, M. Pure & Appl. Chem. 1992, 64, 1121.
19. b) Lafontaine J.A.; Leahy, J.W. Tetrahedron Lett. 1995, 36, 6029.
20. Provencal, D.P.; Gardelli, C.; Lafontaine, J.A.; Leahy, J.W. Tetrahedron Lett. 1995, 36, 6033.
21. Keck, G.E.; Savin, K.A.; Weglarz, M.A.; Cressman, E.N.K. Tetrahedron Lett. 1996, 37, 3291. See also citations in reference 10.
22. Wilt, J.W.; Massie, S.N.; Dabek, R.B. J. Org. Chem. 1970, 35, 2803.
23. a) Gage, J.R.; Evans, D.A. Org. Syn. 1989, 68, 77.
24. b) Gage, J.R.; Evans, D.A. Ibid. 1989, 68, 83.
25. For a related example: McMurry, J.E.; Dushin, R.G. J. Am. Chem. Soc. 1990, 112, 6942.
26. Evans, D.A.; Sjogren, E.B.; Bartroli, J.; Dow, R.L. Tetrahedron Lett. 1986, 27, 4957.
27. 3P at 0 °C.
28. Finan, J.M.; Kishi, Y. Tetrahedron Lett. 1982, 23, 2719.
29. 13C-NMR data for the pair of acetonides individually characterized from desilylation of 16 See: Rychnovsky, S.D.; Skalitzky, D. J. Tetrahedron Lett. 1990, 31, 945.
30. Ley, S.V.; Norman, J.; Griffith, W.P. Marsden, S.P. Synthesis, 1994, 639.
31. Corey, E.J.; Bakshi, R.K.; Shibata, S.; Chen, C.-P.; Singh, V.K. J. Am. Chem. Soc. 1987, 109, 7925. Mathre, D.J.; Jones, T.K.; Xavier, L.C.; Blacklock, T.J.; Reamer, R.A.; Mohan, J.J.; Jones, E.T.T.; Hoogsteen, K.; Baum, M.W.; Grabowski, E.J.J. J. Org. Chem. 1991, 56, 751.
32. Corey, E.J.; Bakshi, R.K.; Shibata, S.; Chen, C.-P.; Singh, V.K. J. Am. Chem. Soc. 1987, 109, 7925. Mathre, D.J.; Jones, T.K.; Xavier, L.C.; Blacklock, T.J.; Reamer, R.A.; Mohan, J.J.; Jones, E.T.T.; Hoogsteen, K.; Baum, M.W.; Grabowski, E.J.J. J. Org. Chem. 1991, 56, 751.
33. 7 alcohol resulting only from removal of the THP ether. However, longer reaction times or increased temperatures led to numerous side products.
34. For an example: Williams, D.R.; McGill, J.M. J. Org. Chem. 1990, 55, 3457, and references therein.
35. Horita, K.; Yoshioka, T.; Tanaka, T.; Oikawa, Y.; Yonemitsu, O. Tetrahedron, 1986, 42, 3021.
36. In practice, our Wittig reactions led to crude product with some hydrolytic opening of the valerolactone. Submission to Yamaguchi conditions (procedure: Suzuki, K.; Tomooka, K.; Katayama, E.; Matsumoto, T.; Tsuchihashi, G. J. Am. Chem. Soc. 1986, 108, 5221) recovered this material prior to purification.